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Background
Identification and quantification of osteoporosis in
patients who have myelomeningocele has been limited
until now but it should be useful in order to improve their
general care and prevent fractures in the future. The aim of
this study was to examine bone mineral density in
patients with myelomeningocele (MMC).
Patients and methods
Eighty patients with myelomeningocele were randomly
chosen from a roster of > 500 patients with (MMC) fol-
lowed at a multidisciplinary spina bifida unit in a third-
level public university hospital, which serves as the refer-
ral centre for these patients in our country. Patients with
known metabolic acidosis, renal insufficiency, or other
metabolic bone disease (i.e., hyperparathyroidism) were
excluded from this study. We measured Bone Mineral
Density (BMD) with total-body DXA scan with subre-
gional areas values and the biochemical markers of bone
mineral metabolism in blood and urine. To study rela-
tionships among the variables, the Chi-squared, ANOVA
and lineal regression tests were applied
Results
The mean total body BMD was 1.1591 (range 0.9–1.38).
Fifty two per cent of the patients were in the normal range
of BMD, 31.6% were osteopenic and 15.8% were oste-
oporotic. The bivariate analysis demonstrated that the
body mass index (p = 0.033) and hip flexion contractures
(p = 0.024) were related with pelvis T-score. Neurological
level (p = 0.038), functional ambulation (p = 0.024) and
hip flexion contractures (p = 0.024) were related with leg
T-score. Hip flexion contractures (p = 0.027) was related
with leg Z-score. The only determinant for leg BMD in the
multivariate approach was type of gait (p = 0.012; 95% CI
0.042–0.229); When we use total-body BMD as depend-
ent variable, the model showed as determinants: type of
gait (p = 0.003; 95% CI 0.031–0.88) and sex (p = 0.044;
95% CI 0.003–0.155).
Conclusion
Fatter MMC (body mass index >25) patients had less oste-
openia or osteoporosis than normal or thin patients. The
higher neurological level, the worse BMD. Although type
of gait is determinate by neurological level, this study sug-
gests that the type of gait is the most important determi-
nant leg and total-body BMD.
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